# FDA recall D-1263-2014

> **Medisca Inc.** · Class I · drug recall initiated 2013-10-21.

## Product

Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law.  Potency 5489.6IU/mg.  Packed by Medisca, Inc. Irving, TX, 75063, USA      NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.      Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16,  CAS 9002-61-3;  and 101799/A, Exp: 05/16, CAS: 9002-61-3

## Reason for recall

Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1263-2014
- **Recalling firm:** Medisca Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-10-21
- **Report date:** 2014-05-07
- **Termination date:** 2016-11-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Irving, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1263-2014

## Citation

> AI Analytics. FDA recall D-1263-2014. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-1263-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*